Seattle Genetics | SGEN - Рыночная капитализация



Рыночная капитализация Изменить Дата
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Amgen USD 209.65B 14.21B 2026-08
Astellas Pharma JPY 4.1T 160.64B 2026-08
Bayer EUR 49.51B 10.82B 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Celldex Therapeutics USD 2.76B 161M 2026-08
Eisai JPY 1.3T 102.92B 2026-08
Eli Lilly USD 1.11T 18.32B 2026-08
Exelixis USD 16.2B 5.3B 2026-08
Genmab DKK 126.96B 109.86B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 26.84B 4.19B 2026-08
Insmed USD 19.68B 3.43B 2026-08
Karyopharm Therapeutics USD 221M 95M 2026-08
MacroGenics USD 184M 82M 2026-03
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 143.89B 5.44B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Takeda JPY 8.2T 809.7B 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Vertex Pharmaceuticals USD 121.59B 4.48B 2026-08
Xencor USD 1.21B 19M 2026-08